The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 24060 participants.
Also called NCT06953778
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose screening
- Phase
- Not applicable
- Enrolled
- 24,060 participants
- Registry
-
NCT06953778
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06953778. Randomized; no masking; primary purpose screening. Start 2027-03-08 (anticipated); primary completion 2032-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome
- Acronym
- VALIANT-AF-S
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Zio XT® Patch
- Lead sponsor
- VA Office of Research and Development
Record details
- Record id
cardio:ct-nct06953778- Content hash
48420ccb14429ddac5defbb6e760cfbd1b1e081d179fe172ef2a9effc01afc99